PMC:7558914 / 28779-29025
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T47 | 59-66 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T48 | 59-66 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T49 | 97-104 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T50 | 97-104 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 681 | 36-44 | Species | denotes | patients | Tax:9606 |
| 682 | 75-83 | Species | denotes | patients | Tax:9606 |
| 685 | 11-22 | Chemical | denotes | tocilizumab | MESH:C502936 |
| 686 | 59-66 | Chemical | denotes | heparin | MESH:D006493 |
| 687 | 97-104 | Chemical | denotes | heparin | MESH:D006493 |
| 691 | 121-143 | Disease | denotes | venous thromboembolism | MESH:D054556 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T54 | 128-143 | Phenotype | denotes | thromboembolism | http://purl.obolibrary.org/obo/HP_0001907 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T183 | 0-246 | Sentence | denotes | The use of tocilizumab for selected patients, prophylactic heparin for all patients, therapeutic heparin for evidence of venous thromboembolism, general symptomatic and supportive care, and hospital organization were recommended in all protocols. |